Combined synopsis and solicitation
ROCHE DIAGNOSTICS LAB SUPPIES
ITSS-2024-00239
Centers for Disease Control and Prevention, CDC Office of Acquisition Services. Biological Product (except Diagnostic) Manufacturing.
Awarded
$25,725.24 obligated so far on USAspending
Get the next one like this from Centers for Disease Control and Prevention by email, the day it is posted.Find my opportunities
This one was awarded in 2024
1 like it is open now in biological product (except diagnostic) manufacturing
- Foot and Mouth Disease (FMD) Vaccine Antigen Concentrate (VAC)
Animal and Plant Health Inspection Service, MRPBS Minneapolis MN
Combined synopsis and solicitationNAICS 325414Anywhere in the US12639527R0001Closes in 9 daysNov 10
Description
As published on SAM.gov.
The Centers for Disease Control and Prevention intends to award a sole source firm fixed price purchase order to procure reagents and testing suppllies required to conduct HIV molecular laboratory testing. Only Roche Diagnostics can provide reagents compatible with the Roche cobas 8800 system. These supplies are proprietary to the manufacturer and there are no authorized resellers.
Roche cobas 8800 instruments are necessary in order to provide HIV-1 viral load and early infant diagnosis testing support, guidance, and training to the many PEPFAR-supported field laboratories with these Roche instruments. If another product is sourced the International Laboratory Branch will be unable to support our international PEPFAR-supported laboratories that use these testing platforms for HIV viral load testing and early infant diagnosis testing of HIV. Only Roche can supply these products.
We propose to contract with Roche Diagnostics 9115 Hague Road, Indianapolis, Indiana 46250 as they are identified as the vendor capable of providing these products. This contract action is for supplies or services for which the Government intends to solicit and negotiate with only one source under the authority of FAR 13.106-l(b) (SAP) and 41 U.S.C. 3304(a). Interested persons may identify their interest and capability to respond to the requirement.
This notice of intent is not a request for competitive quotations; however, all quotations/responses received within seven (7) days of the issuance of this notice will be considered by the government. A determination by the government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the government. Information received will normally be considered solely for the purpose of determining whether to conduct a competitive procurement. Any quotation/response should be emailed to contract specialist at qnt8@cdc.gov by 12pm 24 July 2024.
The contract, on USAspending
Federal procurement data the awarding office reported to FPDS, matched to this solicitation by its number.
- Recipient
- Roche Diagnostics Corporation
- UEI
- JDMDFEZBYH36
- CAGE
- 51169
- Vendor location
- Indianapolis, IN
- Contract
- 75D30124P00060, purchase order
- Obligated
- $25,725.24
- Actions
- 3 between August 5, 2024 and February 25, 2026
- Competition
- Not Competed Under SAP, 1 offer received
- Set-aside reported
- No Set Aside Used.
- Described as
- Biomedical Reagents and Testing Supplies and Commodities Required to Conduct Hiv Molecular Laboratory Testing. Based Off of Quote: Hivproducts07292024 CDC Program Poc: Ernest Yufenyuy; Yod0@cdc.Gov; 404.639.1548
- Match
- solicitation number ITSS202400239 equals the FPDS solicitation identifier; same awarding office 75D301 (high confidence)
- Record
- USAspending award page
Publications
Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.
July 17, 2024
Combined synopsis and solicitation
Due July 24, 2024 at 12:00 PM EDT. SAM.gov, notice 3f81d0408db44204b6ee6fd4d1a3c3ba
Points of contact
- Spencer Kahnqnt8@cdc.gov